SAN FRANCISCO, April 17, 2026 /PRNewswire/ -- A securities class action lawsuit has been filed against Gossamer Bio, Inc. (NASDAQ: GOSS) and an executive, seeking to represent investors who purchased or otherwise acquired Gossamer securities between June 16, 2025 and February 20, 2026....
Hence then, the article about gossamer bio inc goss faces securities class action amid 80 drop on phase 3 prosera trial failure hagens berman was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Gossamer Bio, Inc. (GOSS) Faces Securities Class Action Amid 80% Drop On Phase 3 PROSERA Trial Failure- Hagens Berman )
Also on site :
- SEC recruiting update: Every team’s ranking entering July
- Iran raises the stakes – no negotiations without these conditions
- Legally Blonde Prequel Series Elle Is 'Officially Canon' With The Movie, EPs Confirm — Here's How They Made Sure 'Everything Tracked'